Spriet I - Search Results

1

Antifungal drugs: What brings the future?

Van Daele R, Spriet I, Wauters J, Maertens J, Mercier T, Van Hecke S, Brüggemann R. Van Daele R, et al. Among authors: spriet i. Med Mycol. 2019 Jun 1;57(Supplement_3):S328-S343. doi: 10.1093/mmy/myz012. Med Mycol. 2019. PMID: 31292663 Review.

2

Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients.

Meersseman W, Lagrou K, Maertens J, Wilmer A, Hermans G, Vanderschueren S, Spriet I, Verbeken E, Van Wijngaerden E. Meersseman W, et al. Among authors: spriet i. Am J Respir Crit Care Med. 2008 Jan 1;177(1):27-34. doi: 10.1164/rccm.200704-606OC. Epub 2007 Sep 20. Am J Respir Crit Care Med. 2008. PMID: 17885264

3

Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitis.

Spriet I, Delaere L, Lagrou K, Peetermans WE, Maertens J, Willems L. Spriet I, et al. J Antimicrob Chemother. 2009 Oct;64(4):877-8. doi: 10.1093/jac/dkp306. Epub 2009 Aug 14. J Antimicrob Chemother. 2009. PMID: 19684077 No abstract available.

4

Increasing incidence of mucormycosis in University Hospital, Belgium.

Saegeman V, Maertens J, Meersseman W, Spriet I, Verbeken E, Lagrou K. Saegeman V, et al. Among authors: spriet i. Emerg Infect Dis. 2010 Sep;16(9):1456-8. doi: 10.3201/eid1609.100276. Emerg Infect Dis. 2010. PMID: 20735932 Free PMC article.

5

Pharmacokinetics of voriconazole during continuous venovenous hemofiltration.

Spriet I, Wauters J, Willems L. Spriet I, et al. Ther Drug Monit. 2011 Jun;33(3):372; author reply 372. doi: 10.1097/FTD.0b013e31821f38bf. Ther Drug Monit. 2011. PMID: 21566509 No abstract available.

6

Pharmacokinetic profile of voriconazole in a critically ill patient on therapeutic plasma exchange.

Spriet I, Brüggemann RJ, Annaert P, Meersseman P, Van Wijngaerden E, Lagrou K, Willems L. Spriet I, et al. Ther Drug Monit. 2013 Feb;35(1):141-3. doi: 10.1097/FTD.0b013e31827d76b0. Ther Drug Monit. 2013. PMID: 23296095

7

Activities of systemically administered echinocandins against in vivo mature Candida albicans biofilms developed in a rat subcutaneous model.

Kucharíková S, Sharma N, Spriet I, Maertens J, Van Dijck P, Lagrou K. Kucharíková S, et al. Among authors: spriet i. Antimicrob Agents Chemother. 2013 May;57(5):2365-8. doi: 10.1128/AAC.02288-12. Epub 2013 Feb 12. Antimicrob Agents Chemother. 2013. PMID: 23403433 Free PMC article.

8

The influence of continuous venovenous renal replacement therapy on the plasma disappearance rate of indocyanine green.

Ameloot K, Meersseman P, Wilmer A, Hermans G, Gerits A, Spriet I, Wauters J. Ameloot K, et al. Among authors: spriet i. Intensive Care Med. 2013 Dec;39(12):2231-2. doi: 10.1007/s00134-013-3101-y. Epub 2013 Oct 8. Intensive Care Med. 2013. PMID: 24100945 No abstract available.

9

The Eagle-like effect of echinocandins: what's in a name?

Vanstraelen K, Lagrou K, Maertens J, Wauters J, Willems L, Spriet I. Vanstraelen K, et al. Among authors: spriet i. Expert Rev Anti Infect Ther. 2013 Nov;11(11):1179-91. doi: 10.1586/14787210.2013.841543. Epub 2013 Oct 18. Expert Rev Anti Infect Ther. 2013. PMID: 24134556 Review.

10

Pharmacokinetic changes after placement of a transjugular intrahepatic portosystemic shunt.

De Winter S, Verelst S, Wauters J, Van der Linden L, Verslype C, Willems L, Spriet I. De Winter S, et al. Among authors: spriet i. Eur J Clin Pharmacol. 2014 Mar;70(3):377-8. doi: 10.1007/s00228-013-1629-y. Epub 2013 Dec 19. Eur J Clin Pharmacol. 2014. PMID: 24352633 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

231 results

Search Page

Filters